Connect with us

Entrepreneur

How Progyny is harnessing wearables to deliver data-driven care

Published

on

As women face mounting barriers to essential reproductive care, Progyny is tackling health inequities head-on, harnessing wearable tech, and partnering with employers to make healthcare more accessible, chief operating officer Melissa Cummings tells Femtech World.

Many women and their families face barriers when it comes to accessing essential reproductive care. Financial and legislative restrictions often leave women facing high healthcare costs and experiencing poor clinical outcomes.

Founded in 2016, Progyny – a “global leader” in women’s health – recognises the urgent need to remove these barriers, providing personalised clinical solutions for women’s health and fertility-related issues, and is working with employers, patients and providers to improve access and reduce costs.

“Individuals today face an increasingly fragmented landscape when seeking healthcare, which leads to stressful and costly experiences,” Melissa Cummings, COO at Progyny, tells Femtech World.

“We are committed to streamlining access to essential care while reducing costs for everyone involved.”

Progyny solutions include clinical programming and coaching for fertility, one-on-one member support, personalised surrogacy and adoption coaching and support, a network of fertility specialists, along with integrated Rx and access to digital tools.

Supporting healthy families

With one in six families impacted by infertility, Progeny has developed a benefit model that ensures members have their care covered throughout their treatment, to help these families access the vital care they need.

Its support begins before a person is pregnant and continues throughout pregnancy to support positive outcomes and healthy families.

“We’ve been in the market for nearly a decade and have pioneered the delivery of fertility benefits for the nation’s leading employers,” says Cummings.

“We have since built that foundation to offer comprehensive support for women throughout all stages of life, including preconception, fertility and family building, pregnancy, postpartum, parenting, menopause and midlife.

“Our outcomes prove that comprehensive, inclusive, and intentionally-designed solutions simultaneously benefit employers, patients, and physicians.”

Driven by data

These services are now being integrated into wearable technologies to provide more personalised health support and health programmes for specific conditions that are contributing to life-changing outcomes for its members.

“This year, we’ve expanded our offerings through collaborations with Oura Ring, where we incorporate wearable data and insights into our care team decision-support process, as well as with Hinge Health/Origin to offer support for pelvic floor therapy,” says Cummings.

Progyny’s pelvic floor therapy support now provides access to digital care supported by physical therapists specialising in pelvic health and musculoskeletal care through Hinge Health, and access to Origin’s nationwide in-network pelvic floor physical therapy, both in-person and online, along with personalised care plans.

By incorporating this wearable data, Progyny can identify potential risks earlier and support health goals such as optimising conception attempts or making lifestyle changes.

Equally, with the Oura ring tracking key health metrics such as sleep patterns, cycle insights, cardiovascular health and stress levels, the use of this data helps to lay the groundwork for improved pregnancy and fertility outcomes.

The data can also be used to provide insights during perimenopause or menopause and help to guide lifestyle adjustments.

“Our data-driven model is the foundation to improve clinical outcomes through tracking treatment utilisation, clinical performance, and patient outcomes,” she continues.

“As a result, we have superior outcomes – including higher pregnancy rates, fewer miscarriages, and lower rates of multiple births.”

Bridging the gap

With 59 per cent of women missing work due to menopause symptoms, Progyny provides services that support employers to ensure benefit efficiency without compromising on employee care.

This support ensures equitable access to speciality care from Progyny’s network of leading specialists.

Cummings says: “We work with employers to save healthcare dollars by providing employees with a more comprehensive journey that leads to healthier employees and babies.

“For employees, we provide personalised support through our Progyny Care Advocates, access to top fertility clinics that we have thoroughly and rigorously vetted, and bundled benefits so they can make better healthcare decisions based on their needs, not their wallets.

“We support equitable access to care by bridging the gap between employers, patients, and providers. “

Growing demand for whole-person care

This year, the company has expanded its services through the acquisition of BenefitBump, a parental leave benefits navigation programme, along with launching further maternal health support with the addition of doula services.

“In the coming year, we’re focused on expanding our women’s health platform across the full spectrum: from preconception to menopause,” says Cummings.

“Employers see the impact – 40 per cent of new clients have adopted at least one of these newer services, and we’re just getting started.”

Progyny was recently recognised as Company of the Year at the Femtech World Awards, which Cummings says reflects a growing demand for inclusive, whole-person care.

Entrepreneur

US startup builds wearable hormone tracker

Published

on

Stanford graduates’ startup Clair is building a wearable hormone tracker for women, offering continuous, non-invasive monitoring.

The company, Clair, founded by Jenny Duan and Abhinav Agarwal, aims to build what its founders describe as a research-led, privacy-focused tool to help women see how hormone levels affect daily life.

Duan and Agarwal met in spring 2025 and began working on Clair shortly after. Over the past six months, they have been developing the technology and refining the company’s mission.

The device is designed to address gaps in women’s healthcare. Women remain underrepresented in medical research and clinical trials, leading to limited data and slower progress in understanding women’s health conditions.

According to Clair advisor and Stanford Medicine professor Brindha Bavan, hormone tracking in reproductive healthcare “improves our understanding of the function of and communication between the brain’s pituitary gland and ovaries or testes.

The pituitary gland is a small organ at the base of the brain that produces hormones regulating many bodily functions. The ovaries and testes are the primary reproductive organs that also produce sex hormones.

Hormonal health affects not only fertility and reproduction but also mental health, metabolism, energy levels and overall wellbeing.

Bavan said hormone tracking can “provide insight into menstrual cycle patterns and can aid with both diagnosing and assessing treatment for [various] conditions.”

“[Clair enables] patients [to] gain insight into their personal hormone fluctuations over different time periods,” Bavan said, “and share this information at healthcare visits to better understand and correlate any medical issues they are facing and avoid repeat blood draws.”

The device, which resembles a bracelet worn on the wrist, will connect to a mobile app, allowing all data processing to occur directly on the user’s phone rather than in external data centres.

“The device connects with an app so all of the processing happens on the app itself, not in a data centre like other devices. This is especially important given the current political climate around data privacy,” Agarwal said.

Clair also plans to pursue FDA approval and position itself as a medically credible device rather than solely a lifestyle product. The company is planning to launch a clinical trial at Stanford Medicine this spring.

Duan’s interest in women’s health and technology began as a Stanford undergraduate. At TreeHacks in 2024, she built apps focused on endometriosis, a condition where tissue similar to the lining of the womb grows outside of it.

She said a course on Philanthropy for Sustainable Development was particularly influential. “It was this class that sparked my interest in building a solution in [the women’s healthcare] space,” Duan said.

Continue Reading

Insight

Scaling startups risk increasing gender gaps, study finds

Published

on

Rapidly scaling startups often make rushed hiring choices that disadvantage women, a recent study has found.

The findings draw on more than 31,000 new ventures founded in Sweden between 2004 and 2018.

Researchers at the Stockholm School of Economics report that in male-led startups, scaling reduces the odds of hiring a woman by about 18 per cent, and the odds of appointing a woman to a managerial post by 22 per cent.

Mohamed Genedy is co-author and postdoctoral fellow at the House of Innovation, Stockholm School of Economics.

Genedy  said: “During those moments of rapid growth, even well-intentioned leaders can fall back on familiar stereotypes when assessing who they believe is best suited for the role.”

The patterns emerge even in Sweden, regarded as a highly gender-equal national context.

Founders with human resources-related education counteract these challenges.

In ventures led by founders with HR training, the odds of hiring a woman increase by more than 30 per cent, and the odds of appointing a woman to a managerial role increase by 14 per cent for the same level of growth.

Genedy said: “When founders have experience with structured hiring practices, the gender gaps shrink, and in some cases even reverse.

“This shows that getting the basics of HR right early on really pays off.

“When things start moving fast, founders with HR knowledge are less likely to rely on biased instincts and more likely to hire from a broader talent pool.”

Prior experience in companies with established HR practices also helps, though to a lesser degree.

It raises the likelihood of hiring women as ventures scale, but does not significantly affect managerial appointments.

The study additionally shows these patterns are not driven by founder gender alone.

Even solo female-led ventures display similar tendencies when growing rapidly, though to a somewhat lesser degree.

In female-dominated industries, rapid growth increases the hiring of women for regular roles but still reduces the likelihood that women are appointed to managerial positions.

“When scaling accelerates, cognitive bias kicks in for everyone. Female founders are not immune to these patterns,” said Genedy.

Continue Reading

Entrepreneur

Midi Health closes US$100m Series D

Published

on

Midi Health has closed a US$100m Series D, lifting the menopause care provider to a valuation above US$1bn and achieving unicorn status.

The company, originally focused on virtual menopause care, says it will expand to what it calls lifelong care, adding cardiology, obesity management, autoimmune survivorship and longevity services.

Joanna Strober is co-founder and chief executive officer of Midi Health.

She said: “This is validation for the movement we’re leading.

“Women’s health has been treated like an afterthought for too long.”

Midi reports it now sees more than 25,000 patients per week and has insurance coverage reaching 45 million women nationwide.

To support scale, the firm is rolling out a proprietary artificial intelligence engine intended to slot into clinical workflows.

It analyses patient charts before virtual visits to help personalise care, automates triage and documentation, and reviews data on midlife women to refine protocols.

The company has also strengthened its leadership. Jason Wheeler, formerly in senior finance roles at Tesla and Google, has been appointed chief financial officer. He joins chief marketing officer Melissa Waters, previously at Meta and Lyft, and chief commercial officer Matt Cook.

Each year, about two million women in the US enter menopause.

Untreated symptoms are estimated to cost the economy US$25bn annually.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.